Evidence map›Paper›PMID 33733816›Full record

ArticleJournal of the American Heart Association2021

Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure.

Taiki Nishihara, Eiichiro Yamamoto, Daisuke Sueta, Koichiro Fujisue, Hiroki Usuku, Fumi Oike, Masafumi Takae, Noriaki Tabata, Miwa Ito, Kenshi Yamanaga and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Taiki NishiharaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Eiichiro YamamotoDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Daisuke SuetaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Koichiro FujisueDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Hiroki UsukuDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Fumi OikeDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Masafumi TakaeDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Noriaki TabataDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Miwa ItoDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Kenshi YamanagaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Hisanori KanazawaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Yuichiro ArimaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Satoshi ArakiDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Seiji TakashioDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Taishi NakamuraDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Satoru SuzukiDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Kenji SakamotoDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Yasuhiro IzumiyaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Koichi KaikitaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.
Kumamoto University · JPSuzuki (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background We investigated the clinical significance of derivatives of reactive oxygen metabolites (DROMs), a new marker of reactive oxygen species, in patients with nonischemic heart failure (HF) and compared them among new categories of HF. Methods and Results We recruited 201 consecutively hospitalized patients with HF and measured DROM under stable conditions. Then, we divided them according to new categories of HF (HF with reduced ejection fraction [EF], HF with midrangeEF, and HF with preserved EF) without coronary artery disease. In subgroup analysis, we followed EF changes in patients with HF with reduced EF and classified them into HF with recovered EF or nonrecovered EF according to whether EF had improved to >40%. DROMs are significantly and independently associated with HF-related events in patients with NIHF. There were no significant differences in DROM and the probability of HF-related events among HF categories in Kaplan-Meier analysis. However, patients with HF with reduced EF and HF with preserved EF but not HF with midrange EF with HF-related events had higher DROM than those without HF-related events. In subgroup analysis, Kaplan-Meier analysis demonstrated that the probabilities of HF-related events in HF with recovered EF were dramatically decreased. DROM were significantly higher in patients with HF with nonrecovered EF than in HF with recovered EF. In receiver operating characteristic analysis, the cutoff level of DROM for predicting improvements in HF with recovered EF was 347 Carratelli units. Furthermore, the C-statistic value for predicting EF improvement for the DROM levels was 0.703. In multivariable logistic regression analysis, DROM was independently and significantly associated with the prediction of HF with recovered EF. Conclusions DROM measurements can provide important prognostic information for risk stratification in any category of NIHF. Registration URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000035827.

Indexed as

Heart FailureVentricular Dysfunction, LeftBiomarkersCorrelation of DataEchocardiographyFemaleHumansKaplan-Meier EstimateMaleOxidative StressPrognosisReactive Oxygen SpeciesReproducibility of ResultsRisk AssessmentStroke VolumeBiomarkersReactive Oxygen Speciesfollow‐up studiesnonischemic heart failureprognosisreactive oxygen species

Identifiers

PMID33733816
PMCPMC8174381
OpenAlexW3137111554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.